Clinical Trial Update: Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis [Phase 2]

View source ↗

Summary

Phase 2 trial update for GMI-1070 in sickle cell pain crisis (vaso-occlusive crisis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Crisis
• Sickle Cell Disease
• Vaso-occlusive Crisis

Drugs mentioned

• GMI-1070

Snippet

Sponsor: GlycoMimetics Incorporated | Conditions: Sickle Cell Disease, Vaso-occlusive Crisis | Phase 2 | Status: COMPLETED